ChemoCentryx (CCXI) Debt/EBITDA US GAAP (year values) |
|||||||||
2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | -1.93 | 0.23 | 2.93 | 7.92 | 1.98 | 1.95 | |||
Changes by years, y/y, % | -165% | -112% | +1 164% | +170% | -75% | -7.8% |
ChemoCentryx. Debt/EBITDA
ChemoCentryx. Debt/EBITDA, changes, %
ChemoCentryx (CCXI) Debt/EBITDA US GAAP (quarter values) |
||||||||
2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
Debt/EBITDA | 2.02 | 1.70 | 1.83 | 1.92 | 1.95 | 1.95 | ||
Changes by years, y/y, % | -87% | -85% | -76% | -67% | -4% | |||
Changes by quarters, q/q, % | -65% | -16% | +8% | +5% | +1% |